GLPBio

Senkyunolide I

Catalog No.: GN10801Purity:>99.50%
Senkyunolide I is a natural phthalide existing in L. chuanxiong and A. sinensis with good blood-brain barrier permeability, which has the potential to become a cardio-cerebral vascular drug candidate.

Products are for research use only. Not for human use. We do not sell to patients.


Senkyunolide I
Cas No.: 94596-28-8
10mM (in 1mL DMSO)In Stock
$77.00
1
1mgIn Stock
$35.00
1
5mgIn Stock
$70.00
1
10mgIn Stock
$109.00
1
25mgIn Stock
$196.00
1
50mgIn Stock
$314.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Senkyunolide I is a natural phthalide existing in L. chuanxiong and A. sinensis with good blood-brain barrier permeability, which has the potential to become a cardio-cerebral vascular drug candidate [1]. Its pharmacological effects include analgesic, anti-inflammatory, antioxidant, anti-thrombotic, anti-tumor effects, alleviating ischemia-reperfusion injury, etc [1].

Senkyunolide I (400μM; 2h) significantly attenuated glutamate-induced cytotoxicity, increased the cell viability of Neuro2a cells [2]. Senkyunolide I (20, 50, 100μM; 24h) suppressed the fibrotic markers (α-Sma, Col1a1, and Timp1) in the TGF-β1-stimulated hepatic stellate cells in a dose-dependent manner [3]. Senkyunolide I (200, 400μM; 24h) promoted neural stem/progenitor cells proliferative capacity [4].

Senkyunolide I (36mg/kg; 4 weeks; qow; i.p.) attenuated the ROS and apoptosis in the aortic tissue in the TAAD (thoracic aortic aneurysm and aortic dissection) model C57BL/6J mice [5]. Senkyunolide I (72mg/kg; i.p.) reduced TNF-α, IL-1β levels in sepsis-associated encephalopathy model Sprague-Dawley rats [6].

References:
[1] Huang Y, Wu Y, Yin H, et al. Senkyunolide I: a review of its phytochemistry, pharmacology, pharmacokinetics, and drug-likeness [J]. Molecules, 2023, 28(8): 3636.
[2] Wang M, Hayashi H, Horinokita I, et al. Neuroprotective effects of Senkyunolide I against glutamate-induced cells death by attenuating JNK/caspase-3 activation and apoptosis [J]. Biomedicine & pharmacotherapy, 2021, 140: 111696.
[3] Zhu M, Ren L, Xiao W, et al. Senkyunolide I suppresses hepatic stellate cell activation and liver fibrosis by reprogramming VDR-dependent fatty acid metabolism [J]. Chinese medicine, 2025, 20(1): 85.
[4] Wang M, Hayashi H, Horinokita I, et al. Role of senkyunolide I in the promotion of neural stem/progenitor cell proliferation via the Akt/β-catenin pathway [J]. Biomedicine & pharmacotherapy, 2023, 168: 115683.
[5] Zhao K, Zhu H, He X, et al. Senkyunolide I ameliorates thoracic aortic aneurysm and dissection in mice via inhibiting the oxidative stress and apoptosis of endothelial cells [J]. Biochimica et biophysica acta Molecular basis of disease, 2023, 1869(7): 166819.
[6] Cao H, Liu T, Xu M. Senkyunolide I improves septicemia-induced brain dysfunction via regulating Nrf2 and astrocyte activity [J]. Biotechnology and applied biochemistry, 2025, 72(5): 1385-1394.

Protocol

Cell experiment [1]:

Cell lines

Neuro2a cells

Preparation Method

Cells were seeded at 2×104 cells into 96-well plates and grown for 48h, and then were treated with 150mM glutamate for 24h to obtain the glutamate-induced excitotoxicity cell model. Cells were pre-treated with Senkyunolide I for 2h prior to incubation with glutamate. After 24h, cell viability was measured.

Reaction Conditions

400μM; 2h

Applications

Senkyunolide I significantly attenuated glutamate-induced cytotoxicity, increased the cell viability.
Animal experiment [2]:

Animal models

Male C57BL/6J mice

Preparation Method

The mice were administered with water containing 1mg/kg/day BAPN (β-aminopropionitrile) for 4 weeks, followed by a 3-day infusion of angiotensin II (1000ng/kg/min) via mini-osmotic pumps to induce thoracic aortic aneurysm and aortic dissection (TAAD). Intraperitoneal injections of 1 % DMSO or Senkyunolide I (36mg/kg) were administered at days 7, 14, 21, and 28. Detecting apoptosis in the aortic tissue and immunofluorescence of ROS after sacrificing.

Dosage form

36mg/kg; 4 weeks; qow; i.p.

Applications

Senkyunolide I attenuated the ROS and apoptosis in the aortic tissue compared with the model group.

References:
[1] Wang M, Hayashi H, Horinokita I, et al. Neuroprotective effects of Senkyunolide I against glutamate-induced cells death by attenuating JNK/caspase-3 activation and apoptosis [J]. Biomedicine & pharmacotherapy, 2021, 140: 111696.
[2] Zhao K, Zhu H, He X, et al. Senkyunolide I ameliorates thoracic aortic aneurysm and dissection in mice via inhibiting the oxidative stress and apoptosis of endothelial cells [J]. Biochimica et biophysica acta Molecular basis of disease, 2023, 1869(7): 166819.

Product Documents

Purity:>99.50%Appearance:A solid

Chemical Properties

CAS No.
94596-28-8
Chemical Name
(3Z,6R,7R)-3-butylidene-6,7-dihydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one
SMILES
CCCC=C1C2=C(C(C(CC2)O)O)C(=O)O1
Molecular Formula
C12H16O4
Molecular Weight
224.25
Solubility
DMSO : 100 mg/mL (445.93 mM; Need ultrasonic)
Storage
4°C, protect from light
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Senkyunolide I

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%